Determinants of Natural Killer Cell Ly49 Receptor Specificity
自然杀伤细胞 Ly49 受体特异性的决定因素
基本信息
- 批准号:RGPIN-2016-03744
- 负责人:
- 金额:$ 2.26万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2017
- 资助国家:加拿大
- 起止时间:2017-01-01 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Natural killer (NK) cells are lymphocytes that act as a first line of defense against viruses and tumours, destroying pathologically altered cells. NK cells express inhibitory receptors specific for class I (CI) major histocompatiblity complex molecules ubiquitously expressed on healthy cells. Lack of engagement of NK inhibitory receptors, due to loss of CI expression that typically occurs with virus-infected cells or tumour cells, releases inhibition of NK cells, allowing them to destroy such altered cells. Ly49 are large families of major class of CI-specific receptors expressed by mouse and rat NK cells, but not humans. CI associate with beta-2 microglobulin (b2m) and bind and present peptide fragments from intracellular proteolytic events. We, and others, have found that the identity of the CI-bound peptide can determine Ly49 recognition of CI. What is unclear, is the nature of endogenous peptides in healthy cells that regulate NK cells, and the
自然杀伤细胞(NK)是淋巴细胞,作为抵御病毒和肿瘤的第一道防线,摧毁病理改变的细胞。NK细胞表达在健康细胞上普遍表达的I类(CI)主要组织相容性复合物分子特异性抑制受体。由于CI表达缺失(通常发生在病毒感染细胞或肿瘤细胞中),NK抑制受体的缺失释放了对NK细胞的抑制,使它们能够破坏这种改变的细胞。Ly49是主要一类ci特异性受体的大家族,在小鼠和大鼠NK细胞中表达,但在人类中不表达。CI与β -2微球蛋白(b2m)相关,结合并呈现细胞内蛋白水解事件中的肽片段。我们和其他人发现,CI结合肽的身份可以决定Ly49对CI的识别。目前尚不清楚的是,健康细胞中调节NK细胞的内源性肽的性质是什么
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kane, Kevin其他文献
Microvascular changes in Down syndrome with Alzheimer's-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease
- DOI:
10.1016/j.jalz.2017.05.003 - 发表时间:
2017-12-01 - 期刊:
- 影响因子:14
- 作者:
Drachman, David A.;Smith, Thomas W.;Kane, Kevin - 通讯作者:
Kane, Kevin
The Healthy Kids & Families study: Outcomes of a 24-month childhood obesity prevention intervention.
- DOI:
10.1016/j.pmedr.2022.102086 - 发表时间:
2023-03 - 期刊:
- 影响因子:2.8
- 作者:
Rosal, Milagros C.;Lemon, Stephenie C.;Borg, Amy;Lopez-Cepero, Andrea;Sreedhara, Meera;Silfee, Valerie;Pbert, Lori;Kane, Kevin;Li, Wenjun - 通讯作者:
Li, Wenjun
Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial
- DOI:
10.1016/s0140-6736(14)60689-9 - 发表时间:
2014-05-24 - 期刊:
- 影响因子:168.9
- 作者:
Brar, Somjot S.;Aharonian, Vicken;Kane, Kevin - 通讯作者:
Kane, Kevin
The effective enforcement of HACCP based food safety management systems in the UK
- DOI:
10.1016/j.foodcont.2013.09.016 - 发表时间:
2014-03-01 - 期刊:
- 影响因子:6
- 作者:
Green, Russell M.;Kane, Kevin - 通讯作者:
Kane, Kevin
Recipes for neighborhood development: A machine learning approach toward understanding the impact of mixing in neighborhoods
- DOI:
10.1016/j.landurbplan.2017.03.006 - 发表时间:
2017-08-01 - 期刊:
- 影响因子:9.1
- 作者:
Hipp, John R.;Kane, Kevin;Kim, Jae Hong - 通讯作者:
Kim, Jae Hong
Kane, Kevin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kane, Kevin', 18)}}的其他基金
Determinants of Natural Killer Cell Ly49 Receptor Specificity
自然杀伤细胞 Ly49 受体特异性的决定因素
- 批准号:
RGPIN-2016-03744 - 财政年份:2021
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Determinants of Natural Killer Cell Ly49 Receptor Specificity
自然杀伤细胞 Ly49 受体特异性的决定因素
- 批准号:
RGPIN-2016-03744 - 财政年份:2019
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Determinants of Natural Killer Cell Ly49 Receptor Specificity
自然杀伤细胞 Ly49 受体特异性的决定因素
- 批准号:
RGPIN-2016-03744 - 财政年份:2018
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Determinants of Natural Killer Cell Ly49 Receptor Specificity
自然杀伤细胞 Ly49 受体特异性的决定因素
- 批准号:
RGPIN-2016-03744 - 财政年份:2016
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
Natural超对称中的希格斯物理与暗物质研究
- 批准号:11775039
- 批准年份:2017
- 资助金额:52.0 万元
- 项目类别:面上项目
Natural超对称在LHC上的现象学研究
- 批准号:11405015
- 批准年份:2014
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
SBIR Phase I: Endogenously secreted bispecific natural killer cell engagers (BIKEs) for therapy of solid tumors
SBIR I 期:用于治疗实体瘤的内源性分泌双特异性自然杀伤细胞接合剂 (BIKE)
- 批准号:
2322959 - 财政年份:2024
- 资助金额:
$ 2.26万 - 项目类别:
Standard Grant
Human Leukocyte Antigen-A and -B regulation of Natural Killer cell function
人类白细胞抗原 A 和 B 对自然杀伤细胞功能的调节
- 批准号:
DP230103117 - 财政年份:2023
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Projects
Targeting aerobic glycolysis via hexokinase 2 inhibition in Natural Killer T cell lymphomas
通过抑制己糖激酶 2 靶向自然杀伤 T 细胞淋巴瘤中的有氧糖酵解
- 批准号:
23K07830 - 财政年份:2023
- 资助金额:
$ 2.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Peptide-Specific Natural Killer Cell Receptors in Health and Disease
健康和疾病中的肽特异性自然杀伤细胞受体
- 批准号:
MR/X020746/1 - 财政年份:2023
- 资助金额:
$ 2.26万 - 项目类别:
Fellowship
Using natural killer cells to prevent breast cancer metastases
使用自然杀伤细胞预防乳腺癌转移
- 批准号:
10591362 - 财政年份:2023
- 资助金额:
$ 2.26万 - 项目类别:
Regulation of natural killer cell-mediated immune response in breast cancer
自然杀伤细胞介导的乳腺癌免疫反应的调节
- 批准号:
494926 - 财政年份:2023
- 资助金额:
$ 2.26万 - 项目类别:
Operating Grants
Uncovering the developmental trajectory of Natural Killer cells
揭示自然杀伤细胞的发育轨迹
- 批准号:
2898862 - 财政年份:2023
- 资助金额:
$ 2.26万 - 项目类别:
Studentship
Mechanisms of natural killer cell resistance of treatment-persistent residual tumor cells in hematologic malignancies
血液系统恶性肿瘤中持续治疗残留肿瘤细胞的自然杀伤细胞耐药机制
- 批准号:
10564354 - 财政年份:2023
- 资助金额:
$ 2.26万 - 项目类别:
The natural killer cell response against mouse cytomegalovirus infection
自然杀伤细胞对小鼠巨细胞病毒感染的反应
- 批准号:
10669344 - 财政年份:2023
- 资助金额:
$ 2.26万 - 项目类别:
Project 4: Off-the-shelf engineered cord blood-derived natural killer cells for the treatment acute lymphoblastic leukemia
项目 4:现成的工程化脐带血自然杀伤细胞,用于治疗急性淋巴细胞白血病
- 批准号:
10931069 - 财政年份:2023
- 资助金额:
$ 2.26万 - 项目类别: